manual-prevencion

MANUAL SEOM DE PREVENCIÓN Y DIAGNÓSTICO PRECOZ DEL CÁNCER 200 6. BIBLIOGRAFÍA 1. Ferlay J, Soerjomataram I, ErvikM, et al. GLOBOCAN2012 v1.0, Cancer Incidence andMortalityWorldwide: IARCCancerBase. No. 11 [Internet]. Lyon, France: International Agency for ResearchonCancer. doi:10.1016/j.ucl.2013.01.011. 2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence andmortality patterns in Europe: Estimates for 40 countries in2012. Eur JCancer . 2013;49(6):1374-1403. doi:10.1016/j.ejca.2012.12.027. 3. Galceran J, AmeijideA, CarullaM, et al. Cancer incidence in Spain, 2015. ClinTranslOncol . January 2017. doi:10.1007/s12094-016-1607-9. 4. Área de EpidemiologíaAmbiental y Cáncer. Mortalidadpor cáncer en España. http://www.isciii.es/ISCIII/es/contenidos/fd-servicios- cientifico-tecnicos/fd-vigilancias-alertas/fd-epidemiologia-ambiental-y-cancer/mortalidad-cancer-en-espana.shtml. Published2017. AccessedApril 24, 2017. 5. PollánM, Pastor-BarriusoR, Ardanaz E, et al. Recent changes inbreast cancer incidence in Spain, 1980-2004. JNatlCancer Inst . 2009;101(22):1584-1591. doi:10.1093/jnci/djp358. 6. AscunceN, SalasD, Zubizarreta R, et al. Cancer screening in Spain. AnnOncol . 2010;21(SUPPL.3):43-51. doi:10.1093/annonc/mdq085. 7. PollánM, MichelenaMJJ, Ardanaz E, et al. Breast cancer incidence in Spainbefore , during and after the implementationof screening programmes. AnnOncol . 2010;21(Supplement 3):97-102. doi:10.1093/annonc/mdq095. 8.Warner E. Breast-Cancer Screening. NEngl JMed . 2011;365(11):1025-1032. doi:10.1056/NEJMcp1101540. 9. Cobain EF, MillironKJ, Merajver SD. Updates onbreast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility tobreast cancer. SeminOncol . 2016;43(5):528-535. doi:10.1053/j.seminoncol.2016.10.001. 10. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. AnnOncol . 2015;26(7):1291-1299. 11. Skol AD, Sasaki MM, Onel K.Thegenetics of breast cancer risk in thepost-genome era: thoughts on study design tomovepast BRCA and towards clinical relevance. BreastCancerRes . 2016;18(1):99. doi:10.1186/s13058-016-0759-4. 12. PikeMC, PearceCL,WuAH. Preventionof cancers of thebreast , endometriumandovary. 2004:6379-6391. doi:10.1038/sj.onc.1207899. 13. Cabanes A, AscunceN,Vidal E, et al. Decline in age atmenarche among Spanishwomenborn from1925 to1962. BMCPublicHealth . 2009;9:449. doi:10.1186/1471-2458-9-449. 14. EuropeanCommision. EUROSTAT: Births and fertility data. http://ec.europa.eu/eurostat/web/population-demography-migration- projections/births-fertitily-data. Published2015. 15.WorldCancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report: Food, Nutrition, Physical Activity and the Preventionof Breast Cancer; 2017. Available at: wcrf.org/breast-cancer-2017. 16. IARCWorkingGroupon the Evaluationof Carcinogenic Risks toHumans. AReviewofHumanCarcinogens. PartA: Pharmaceuticals . (IARC mongraphs, ed.). Lyon: IARC; 2012. http://monographs.iarc.fr/ENG/Monographs/vol100A/mono100A.pdf. AccessedApril 25, 2017. 17. for theWomen’s Health Initiative Investigators. Risks andBenefits of EstrogenPlus Progestin inHealthy PostmenopausalWomen: Principal Results FromtheWomen’s Health Initiative RandomizedControlledTrial. Jama . 2002;288(3):321-333. doi:10.1001/ jama.288.3.321. 18. RavdinPM, CroninKA, Howlader N, et al.TheDecrease inBreast-Cancer Incidence in2003 in theUnitedStates. NEngl JMed . 2007;356(16):1670-1674. doi:10.1056/NEJMsr070105. 19. IsidoroB, LopeV,WhelanD, et al. Use of hormone therapy and isoflavones andmammographic density in Spain. Menopause . 2016;23(5):1-10. doi:10.1097/GME.0000000000000569. 20. FinucaneMM, Stevens GA, CowanMJ, et al. National, regional, andglobal trends inbody-mass index since 1980: systematic analysis of healthexamination surveys andepidemiological studieswith960 country-years and9·1millionparticipants. Lancet . 2011;377(9765):557-567. doi:10.1016/S0140-6736(10)62037-5. 21. RenehanAG, ZwahlenM, EggerM. Adiposity and cancer risk: newmechanistic insights fromepidemiology. NatRevCancer . 2015;15(8):484-498. doi:10.1038/nrc3967. 22. PierobonM, FrankenfeldCL. Obesity as a risk factor for triple-negativebreast cancers: A systematic reviewandmeta-analysis. Breast CancerResTreat . 2013;137(1):307-314. doi:10.1007/s10549-012-2339-3. 23. CatsburgC, KirshVA, SoskolneCL, et al. Associations between anthropometric characteristics, physical activity, andbreast cancer risk in a Canadian cohort. BreastCancerResTreat . 2014;145(2):545-552. doi:10.1007/s10549-014-2973-z. 24. LopeV, MartínM, CastellóA, et al. Physical activity andbreast cancer risk by pathological subtype. GynecolOncol . 2017;144(3):577-585. doi:10.1016/j.ygyno.2016.12.014. 25. Jung S,WangM, AndersonK, et al. Alcohol consumption andbreast cancer risk by estrogen receptor status : in a pooled analysis of 20 studies. Int JEpidemiol . 2015;(August 2015):1-13. doi:10.1093/ije/dyv156. 26. Albuquerque RCR, BaltarVT, Marchioni DML. Breast cancer anddietary patterns: A systematic review. NutrRev . 2014;72(1):1-17. doi:10.1111/nure.12083. 27. CastellóA, PollánM, Buijsse B, et al. SpanishMediterraneandiet andother dietary patterns andbreast cancer risk: case-control EpiGEICAMstudy. Br JCancer . 2014;111(April):1-9. doi:10.1038/bjc.2014.434. 28.Toledo E, Salas-Salvadó J, Donat-Vargas C, et al. MediterraneanDiet and Invasive Breast Cancer RiskAmongWomen at High Cardiovascular Risk in the PREDIMEDTrial. JAMA InternMed . 2015;175(11):1. doi:10.1001/jamainternmed.2015.4838.